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The number of people being diagnosed with end-stage renal disease is increasing globally. Therapeutic
options to slow or halt the progression of kidney disease are limited and are not always successful,
despite the increasing body of research and number of basic scientiﬁc reports in this ﬁeld. Further studies
are required to investigate new approaches to renal pathophysiology. State of the art optical imaging is a
powerful tool used to non-invasively observe the pathophysiology of small animals and has the potential
to elucidate the unknown mechanisms of renal disease and aid in our understanding of the disease. This
paper is a brief summary of the current usefulness of intravital imaging using multiphoton microscopy
and discusses possible future applications of the technique.
© 2016 The Authors. Production and hosting by Elsevier B.V. on behalf of Japanese Pharmacological
Society. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
licenses/by-nc-nd/4.0/).1. Introduction
Multiphoton microscopy is a powerful tool that can be used to
analyze physiology in vivo. Although there were initial technical
difﬁculties in observing peripheral organs, especially by using an
upright microscope, several supporting devices have been devel-
oped and it is now easier to access the target organs. Additionally,
developments in biotechnology have allowed for targeted cell
ﬂuorescence in mice and rats. While studies using these genetically
modiﬁed mice and rats have shown the usefulness of intravital
imaging to address a number of physiological questions, there are
alternative techniques to visualize the physiology of animals. This
article reviews the current availability of intravital imaging using
multiphoton microscopy for the analysis of renal pathophysiology,
such as acute kidney injury and glomerular permeability, especially
focusing on techniques that do not use genetically modiﬁed mice,
and also examines pharmacological experiments and discusses the
future application of such methods for the treatment of kidney
disease.
2. Acute kidney injury
Acute kidney injury (AKI) is a common clinical syndrome
deﬁned as the sudden onset of reduced renal function andNakano).
rmacological Society.
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d/4.0/).characterized by a reduction in the glomerular ﬁltration rate (GFR)
and oliguria (1,2). Although basic research has identiﬁed several
pathways involved in the mechanisms of AKI (3e6) which has
enabled the development of new therapeutic strategies, speciﬁc
treatments that can improve AKI outcome are not yet clinically
available (7e9). Molitoris et al. from Indianapolis University are
the ﬁrst to introduce multiphoton in vivo imaging (10) as a useful
tool to detect dynamic changes in the renal environment during
AKI. Even though there are limits in accessibility, with observation
being restricted to superﬁcial areas (<100 mm from the surface),
this technique, combined with the genetic engineering of mice,
holds promise in exploring the hidden mechanisms behind AKI
pathology and for evaluation of the efﬁcacy of new therapeutic
strategies (11).
Acute tubular necrosis, cell sloughing, and cast formation are
typical histopathological changes observed in ischemic AKI. These
pathological changes are often seen in themedullary region, but also
can be observed in the cortical region using in vivo multiphoton
imaging (Figs. 1 and 2, and Supplementary Movie 1, 2 and 3).
Supplementary video related to this article can be found at
http://dx.doi.org/10.1016/j.jphs.2016.08.001.
As seen in Fig.1 and SupplementaryMovie 1 and 2, wewere able
to observe both tubular cell sloughing and the subsequent migra-
tion of tubular cells in the wound healing process in vivo. It is
classically hypothesized that the ‘hole’ in the proximal tubular
monolayer after cell detachment closes with the migration of sur-
rounding cells that have survived the trauma. To the best of our
knowledge, our data are the ﬁrst to conﬁrm this hypothesis.nese Pharmacological Society. This is an open access article under the CC BY-NC-ND
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Fig. 1. Cell sloughing in the ischemia/reperfusion injury kidney. Cell nuclei were stained with Hoechst 33342 and plasma was stained with Evans blue-conjugated albumin at 24 h
after reperfusion. The faint dot-like green ﬂuorescence was derived from tubular auto-ﬂuorescence, and the dark space between the green ﬂuorescence represents the tubular
lumen. (A) The two cells indicated by white arrows at 40 s were sloughed away at 20 s and 0 s. (B) The distance between the two nuclei of the adjacent cells in the enlarged
image (right, top) began to shorten immediately after sloughing and stablized within 300 s. The image at 300 s (A) shows that the wound created by cell sloughing had healed
through mitosis of the surrounding cells.
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Fig. 2. Cellular cast formation in the ischemia/reperfusion injury kidney. Cell nuclei were stained with Hoechst 33342 and plasma was stained with Evans blue-conjugated albumin
at 24 h after reperfusion. Strong ﬂuorescence in S1 proximal tubules was derived from quinacrine. Arrows indicate: proximal tubular lumen dwindled at 92 s; some nuclei appeared
in the tubular lumen at 115 s; nuclei ﬂowed downstream of the tubule at 116 s; nuclei appeared in another tubule in the imaging window at 120 s; and nuclei created cellular casts
at 198 s.
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tion of cells, and the wound created by the loss of the two cells in
the image healed within 300 s (Fig. 1B). This quick healing response
may preserve the tubular monolayer after massive numbers of cell
death even though it results in a shortening of the nephron length
(12). We also observed that cellular cast formation could occurwithin 1 min (Fig. 2, and Supplementary Movie 3) but failed to
observe other events such as clearance of debris (13,14) and repair
of tubules with the proliferation of cells that survived (15). These
events may take a longer time to occur in comparison with our
observation time (24e25 h after ischemia/reperfusion injury), or
occur deeper within the nephron, such as in the medullary region,
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reperfusion injury.
AKI induces irregular capillary blood ﬂow and a reduction/
cessation in the supply of oxygen from red blood cells (16e18).
Prolonged hypoxia, which potentially accelerates atherosclerotic
changes of vessels (19), limits mitochondrial activity and ATP pro-
duction. As tubular cells require large amounts of energy not only
for cell survival but also for reabsorption of electrolytes and other
substances, hypoxia further exacerbates the injury.
Mitochondria play an important role in recovery from damage
induced by AKI (20,21), and are now a therapeutic target (22). It
would be very useful if multiphoton imaging enabled the mea-
surement of mitochondrial activity and ATP production in vivo. Hall
et al. (23) have reported that changes in mitochondrial membrane
potential were able to be visualized using NADH-derived auto-
ﬂuorescence or the ﬂuorescence dye tetramethylrhodaminemethyl
ester. We found large heterogeneity in mitochondrial membrane
potential measured using tetramethylrhodamine methyl ester at
the kidney surface, and signiﬁcant co-localization between a low
tetramethylrhodamine methyl ester signal and disrupted blood cell
ﬂow in adjacent capillaries in the endotoxemic kidney (18). Visu-
alization of ATP at high resolution using multiphoton microscopy is
still being developed.
Autophagy has been implicated as a compensatory phenome-
non against the development of tubular damage (24e27). There are
several challenges with transgenic models aimed at visualizing
autophagic ﬂux in vivo (28e30), as it is recognized that simply
measuring the amount of one molecule, such as LC-3, does not
reﬂect autophagy (31). To the best of the authors' knowledge, there
is little information on the involvement of dynamic functional
changes in AKI, such as hemodynamic changes and autophagy.
Analysis of ischemic AKI can be performed as either a histo-
pathological or a physiological (functional) examination. Notably,
only modest histological changes in the kidney have been
observed in septic AKI (32,33), one of the major causes of AKI with
a high mortality rate. Such limited observations using a histo-
pathological approach suggest the need for further studies of
septic AKI using a physiological approach. Oliguria is one of the
major functional changes seen with AKI and is a criterion for AKI
(34e36). Reduction in urine output is thought to depend on a
reduced GFR induced by hypoperfusion and/or intravascular
depletion. In the intensive care unit, maintaining hemodynamics
by ﬂuid resuscitation and treatment with additional vasoactive
agents frequently fails to restore urine output. The mechanism by
which urine output decreases or is halted, even when renal cir-
culation appears to be normally maintained, has not yet been fully
clariﬁed. Furthermore, there is no consensus on the use of di-
uretics for oliguric patients. Consideration of these problems led
us to examine the physiology of septic AKI using multiphoton
microscopy in vivo (37e39). Intravital imaging enables real-time
in vivo analysis of intra-tubular urine ﬂow rate after a bolus in-
jection of freely ﬁltered dye (such as conjugated inulin with ﬂu-
oresceinyl isothiocyanate), and this simple technique can directly
measure the post-glomerular urine ﬂow rate in the kidneys of
experimental animals. Analysis of the intra-tubular urine ﬂow rate
using multiphoton microscopy revealed that lipopolysaccharide
signaling through a toll-like receptor 4-dependent mechanism is
associated with a reduced intra-proximal tubular urine ﬂow rate
(18). Neither hypotension nor reduction in GFR were likely the
essential factor initiating oliguria, suggesting the potential need
for a therapy targeting proximal tubular injury in addition to he-
modynamic maintenance in AKI patients.
Ascending urinary tract infection in pyelonephritis causes acute
renal failure as well as AKI. Richter-Dahlfors' group (40e42)
visualized an Escherichia coli infection by microinjection of greenﬂuorescent protein-expressing E. coli into either the bladder or
tubules. The studies revealed processes of colonization, infection
of the closed circulation system, tubular obstruction by the colony,
and microcirculation failure in the peritubular capillaries.
Although the studies used adult rats, this technique is applicable
to infant rats or mice and could aid research on pediatric
pyelonephritis.
3. Glomerular ﬁltration barrier
Multiphoton microscopy is now used for the imaging of
glomerular function in Munich Wistar or Munich Wistar Fr€omter
rats, with these strains having glomeruli through the juxtame-
dullary to just beneath the kidney capsule, and young mice. An
alternative method is to transplant glomeruli into the anterior
chamber of the eye, which enables non-invasive long-term serial
analysis (43).
Measuring the glomerular sieving coefﬁcient (GSC) has drawn
increasing interest from researchers. GSC used to be measured
using micro-puncture (44), which involves a relatively difﬁcult
technique and careful handling of equipment and samples. It was
thought that multiphoton microscopy would enable the quick and
easy analysis of protein ﬁltration from glomeruli by comparing the
ﬂuorescence intensity of the ﬂuorophore-conjugated target protein
in plasma and Bowman's space. As it turns outs, multiphoton
analysis of GSC is inﬂuenced by the many possible experimental
settings (45), resulting in international debate on the analysis
technique.
Limitations of multiphoton analysis of GSC include the
following: 1) part of the protein conjugated to the dye might be
nonspeciﬁcally catalyzed into small fragments in the blood and
ﬁltered by glomeruli, which gain the ﬂuorescent intensity in the
Bowman's space independent of the ﬁltration of full-length pro-
tein; 2) detector settings could artiﬁcially overestimate ﬂuores-
cence intensity in the Bowman's space; and 3) as we could analyze
GSC only from a small number of glomeruli in the kidney (<20
superﬁcial glomeruli from a rat and a few from a mouse) in vivo
even by using multiphoton microscopy, it is not possible to pro-
pose that GSC values measured by multiphoton images are
representative of GSC of all nephrons, although GSC values
measured by multiphoton microscopy strongly correlated with
albuminuria in Munich Wistar Fr€omter rats (39). Furthermore,
pathological changes in glomeruli are observed relatively early in
juxtamedullary glomeruli, which are inaccessible by multiphoton
imaging, compared with superﬁcial glomeruli (46); therefore, GSC
values of juxtamedullary glomeruli might be higher than values
reported in the study using multiphoton microscopy. The ‘true’
GSC value would be even smaller than that which the researchers
recorded using a two-photon microscopy technique (39). Indeed,
in a recent study by Mori et al., the whole kidney GSC using mice
absent for megalin, a protein responsible for clathrin-dependent
endocytosis in renal proximal tubules, was reported to be lower
than 0.00002 (47).
GSC analysis using multiphoton microscopy would be useful
for comparing inter-group differences (11,39,48e50) rather than
analyzing the absolute value of GSC itself (though there are
limitations in terms of glomeruli number and region at present).
Comparing the GSC at the same experimental setting could
reveal the protective/exaggerative effects of drugs/gene modiﬁ-
cation on the glomerular ﬁltration barrier. In addition, multi-
photon analysis of glomeruli could aid in examining cellecell
interactions and subsequent changes in GSC in the glomerular
ﬁltration barrier (51,52). Studies are, to date, mainly focusing on
podocyteepodocyte or podocyteeparietal cell interactions. Peti-
Peterdi's group used genetically modiﬁed podocyte-speciﬁc
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transfer of intracellular Ca2þ through a podocyte to adjacent
podocytes via the ATP/purine receptor-dependent pathway (51).
It is theoretically possible to examine the interaction of each cell
in glomeruli; for example, between endothelial cells and podo-
cytes, podocytes and parietal cells (52), and leukocytes and
endothelial cells (53).
Proximal tubules reabsorb protein leaked from the glomerular
ﬁltration barrier. There is a detectable intensity in ﬂuorescence in
proximal tubules of animals that have been administered
ﬂuorophore-conjugated proteins intravenously, indicating prox-
imal tubular uptake of the ﬁltered proteins. However, we do not
recommend quantitative analysis of tubular reuptake of dye-
conjugated proteins for the following reasons. First, tubular ﬂuo-
rescence intensity will be inﬂuenced by the distance from the
glomerulus (upstream tubules have an increased uptake). There-
fore, proximal tubular ﬂuorescence intensity should only be
analyzed at the origin of the proximal tubule, this being the S1
segment. However, the depth of the S1 segment from the kidney
surface is different for each glomerulus, which means that it is not
possible to analyze tubular ﬂuorescence intensity using the same
laser power and detector settings. We cannot eliminate the possi-
bility that both the capsule itself and the blood cells in stellate veins
scatter the ﬂuorescence even if glomeruli exist at the ‘surface’ of the
kidney in Munich Wistar strains. Second, since there is a difference
in the sieving coefﬁcient for each glomerulus, it is necessary to
analyze multiple S1 segments from one kidney, which is very
difﬁcult to do in mice. Third, few studies have clariﬁed the basal
metabolism of the target protein that is conjugated with the ﬂuo-
rophore in vivo, and it is hard to distinguish whether: 1) small
fragmented proteins in plasma that are still conjugated to the dye
passed through the glomerular ﬁltration barrier and were taken up
and accumulated in proximal tubules; or 2) dye-conjugated full
length proteins passed through the glomerular ﬁltration barrier
and were taken up in proximal tubules and degraded in lysosomes,
accumulating as small fragments in proximal tubules. We observed
that the majority of ﬂuorophore-conjugated proteins in the kidney
parenchyma had been degraded into small fragments (>15 kDa)
within 90 min after intravenous injection (39). Therefore, it is
difﬁcult to assess what amount of the target protein (and not
already fragmented metabolites) is actually taken up in proximal
tubules. Taken together, it is suggested that using multiphoton
microscopy for quantitative analysis of proximal tubular protein
uptake is not suitable.
4. Conclusion
Intravital imaging of the kidney with multiphoton microscopy
has the potential to help answer questions on renal physiology,
even without the use of gene-modiﬁed ﬂuorescent mice; for
example, blood cell velocity, tubular ﬂow rate, mitochondrial
membrane potential, and glomerular permeability. The patho-
physiological features explored and identiﬁed using intravital im-
aging could be targets for drug therapy and further
pharmacological studies.
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